Skip to main content

Advertisement

SpringerLink
Log in

Erectile dysfunction as a marker for vascular disease

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

A body of evidence from basic science and clinical research is emerging to provide a compelling argument for endothelial dysfunction as a central etiologic factor in the development of atherosclerosis and systemic vascular diseases (hypertension, dyslipidemia, diabetes, ischemic heart disease, stroke, or claudication). Erectile dysfunction (ED) is another prevalent vascular disorder that, like cardiovascular disease, is now thought to be caused by endothelial dysfunction. In fact, a burgeoning literature is now available that suggests that ED may be an early marker for atherosclerosis, cardiovascular risk, and subclinical systemic vascular disease. The emerging awareness of ED as a barometer for vascular health and occult cardiovascular disease represents a unique opportunity for primary prevention of vascular disease in all men. Although the implications of this relationship for primary and secondary prevention of cardiovascular disease are not fully appreciated, the available literature makes a strong argument for the role of ED as an early marker for the development of significant cardiovascular risk factors and cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Murray CJL, Lopez AD: The Global Burden of Disease and Injury Series, Volume 1: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.

    Google Scholar 

  2. NIH Consensus Development Panel on Impotence: NIH Consensus Conference: impotence. JAMA 1993, 270:83–90.

  3. Derby CA, Mohr BA, Goldstein I, et al.: Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk? Urology 2000, 56:302–306.

    Article  PubMed  CAS  Google Scholar 

  4. Maas R, Schwedhelm E, Albsmeier J, Boger RH: The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 2002, 7:213–225.

    Article  PubMed  Google Scholar 

  5. Feldt-Rasmussen B: Microalbuminuria, endothelial dysfunction, and cardiovascular risk. Diabetes Metab 2000, 26(suppl 4):64–66.

    PubMed  CAS  Google Scholar 

  6. Jeremy JY, Angelini GD, Khan M, et al.: Platelets, oxidant stress, and erectile dysfunction: an hypothesis. Cardiovasc Res 2000, 46:50–54.

    Article  PubMed  CAS  Google Scholar 

  7. Jones RW, Rees RW, Minhas S, et al.: Oxygen-free radicals and the penis. Expert Opin Pharmacother 2002, 3:889–897.

    Article  PubMed  CAS  Google Scholar 

  8. Solomon H, Man JW, Jackson G: Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003, 89:251–253.

    Article  PubMed  CAS  Google Scholar 

  9. Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802–1813.

    Article  PubMed  CAS  Google Scholar 

  10. Feldman HA, Goldstein I, Hatzichristou DG, et al.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151:54–61.

    PubMed  CAS  Google Scholar 

  11. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281:537–544.

    Article  PubMed  CAS  Google Scholar 

  12. Virag R, Bouilly P, Frydman D: Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985, 1:181–184.

    Article  PubMed  CAS  Google Scholar 

  13. Jackson G: Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999, 53:363–368.

    PubMed  CAS  Google Scholar 

  14. Sullivan ME, Keoghane SR, Miller MA: Vascular risk factors and erectile dysfunction. BJU Int 2001, 87:838–845.

    Article  PubMed  CAS  Google Scholar 

  15. Bacon CG, Hu FB, Biovannucci E, et al.: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002, 25:1458–1463.

    Article  PubMed  Google Scholar 

  16. Moulik PK, Hardy KJ: Hypertension, anti-hypertensive drug therapy, and erectile dysfunction in diabetes. Diabet Med 2003, 20:290–293.

    Article  PubMed  CAS  Google Scholar 

  17. Jensen J, Lendorf A, Stimpel H, et al.: The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999, 12:271–275.

    Article  PubMed  CAS  Google Scholar 

  18. Wei M, Macera CA, Davis DR, et al.: Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994, 140:930–937.

    PubMed  CAS  Google Scholar 

  19. Bacon CG, Mittleman MA, Kawachi I, et al.: Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003, 139:161–168.

    PubMed  Google Scholar 

  20. Kirby M, Jackson G, Betteridge J, Friedli K: Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract. 2001, 55:614–618.

    PubMed  CAS  Google Scholar 

  21. Rehman J, Melman A: Normal anatomy and physiology. In Male Sexual Function: A Guide to Clinical Management. Edited by Mulcahy JJ. Totowa, NJ: Humana Press; 2001:1–46.

  22. Sullivan ME, Thompson CS, Dashwood MR, et al.: Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999, 43:658–665.

    Article  PubMed  CAS  Google Scholar 

  23. Kaiser DR, Billups K, Mason C, et al.: Impaired brachial artery endothelium-dependent and-independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004, 43:179–184. This paper compares men with ED and no known risk factors for cardiovascular disease with healthy control subjects without ED using brachial artery endothelial function testing. The ED group was found to have evidence for abnormal endothelial-dependent and endothelial-independent function despite the absence of the usual risk factors for atherosclerosis. The presence of ED should alert physicians to the possible presence or future development of vascular disease.

    Article  PubMed  Google Scholar 

  24. Bocchio M, Desideri G, Scarpelli P, et al.: Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol 2004, 171:1601–1604. This paper uses biochemical markers of endothelial cell activation to examine men with ED and no clinical risk factors for cardiovascular disease and healthy control subjects without ED. The finding that men with ED and no risk factors have significantly elevated markers for endothelial cell activation compared with healthy control subjects supports the concept that ED should prompt physicians to aggressively search for vascular disease even in men who appear benign.

    Article  PubMed  Google Scholar 

  25. Bocchio M, Scarpelli P, Necozione S, et al.: Intima-media thickening of common carotid arteries is a risk factor for severe erectile dysfunction in men with vascular risk factors but no clinical evidence of atherosclerosis. J Urol 2005, 173:526–529.

    Article  PubMed  Google Scholar 

  26. Araujo AB, Zilber SM, O’Donnell AB, McKinlay JB: Erectile dysfunction and stroke risk in aging men: prospective results from the Massachusetts Male Aging Study. J Urol 2005, 173:291.

    Google Scholar 

  27. Guay AT, Perez JB, Heatley GF: Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract 1998, 4:23–26.

    PubMed  CAS  Google Scholar 

  28. Guay AT, Perez JB, Jacobson J, Newton RA: Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001, 22:793–797.

    PubMed  CAS  Google Scholar 

  29. Esposito K, Giugliano F, Palo C, et al.: Effect of lifestyle changes on erectile dysfunction in obese men. JAMA 2004, 291:2978–2984.

    Article  PubMed  CAS  Google Scholar 

  30. Saltzman E, Guay A, Jacobson J: Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004, 172:255–258.

    Article  PubMed  Google Scholar 

  31. Billups K, Bank A, Padma-Nathan H, et al.: Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005, 2:40–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The EpiCenter for Sexual Health & Medicine, 7455 France Avenue South, Suite 362, 55435, Edina, MN, USA

    Kevin L. Billups MD

Authors
  1. Kevin L. Billups MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Billups, K.L. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep 6, 439–444 (2005). https://doi.org/10.1007/s11934-005-0039-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-005-0039-9

Keywords

Search

Navigation